The vector of anti-Tyrosinase T cell receptor (TCR) is constructed for the engineering of T cell to target Human Tyrosinase. The T cells are genetically modified through transduction with a lentiviral vector expressing Tyrosinase-specific T cell receptor. And the vector product was designed for the treatment of Melanomas, gliomas , glioblastoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L117Z||Murinized anti-tyrosinase (aa369-377) T cell receptor, pCDTCR1|
|TCR-L119Z||Human anti-tyrosinase (aa369-377) T cell receptor (Codon optimized), pCDTCR1|
|TCR-L119||Murinized (from Human) anti-TYR (YMDGTMSQV) T Cell Receptor[Cysteine-modiﬁed], pMSGV1|
|VP-TCR-C572||Lenti-Tyrosinase Murinized T cell receptor Viral Particle|
|TCR-L258||Human anti-Tyrosinase T cell receptor (B12), pCDTCR1|
|TCR-L118Z||Murinized anti-tyrosinase (aa369-377) T cell receptor (Cysteine-modiﬁed), pCDTCR1|
|CAR-YJ934||Anti-TYR (SPM360) h(CD28-CD3ζ) CAR, pCDCAR1|
|TCR-L256||Human anti-Tyrosinase T cell receptor (T43), pCDTCR1|
|CAR-YJ436||Anti-TYR (TRSN1-1) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-YJ434||Anti-TYR (SPM360) h(41BB-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved